M1 Kliniken AG (FRA:M12)

Market Cap	340.67M +17.3%
Revenue (ttm)	354.98M +6.5%
Net Income	17.74M +5.9%
EPS	0.95 +4.5%
Shares Out	n/a
PE Ratio	19.20
Forward PE	19.14
Dividend	0.50 (2.99%)
Ex-Dividend Date	Jul 17, 2025

Volume	n/a
Average Volume	119
Open	16.74
Previous Close	17.00
Day's Range	16.74 - 16.74
52-Week Range	12.88 - 19.48
Beta	n/a
RSI	37.78
Earnings Date	Jun 1, 2026

About M1 Kliniken AG

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; abdominoplastic and nose correction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segmen...

• Industry: Hospitals
• Founded: 2007
• Employees: 199
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: M12

Financial Performance

In 2024, M1 Kliniken AG's revenue was 339.18 million, an increase of 7.23% compared to the previous year's 316.32 million. Earnings were 16.02 million, an increase of 55.91%.